Prosight Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-115,100
| Closed | -$184K | – | 41 |
|
|
2021
Q2 | $184K | Sell |
115,100
-382,742
| -77% | -$612K | 0.12% | 44 |
|
|
2021
Q1 | $876K | Sell |
497,842
-385,372
| -44% | -$678K | 0.72% | 30 |
|
|
2020
Q4 | $1.72M | Buy |
883,214
+347,890
| +65% | +$678K | 0.8% | 25 |
|
|
2020
Q3 | $1.28M | Sell |
535,324
-763,976
| -59% | -$1.83M | 0.61% | 36 |
|
|
2020
Q2 | $3.81M | Buy |
1,299,300
+56,600
| +5% | +$166K | 1.63% | 21 |
|
|
2020
Q1 | $3.58M | Buy |
+1,242,700
| New | +$3.58M | 1.67% | 21 |
|
|
2019
Q4 | – | Sell |
-548,409
| Closed | -$2.44M | – | 37 |
|
|
2019
Q3 | $2.44M | Buy |
548,409
+362,688
| +195% | +$1.61M | 1.35% | 25 |
|
|
2019
Q2 | $719K | Buy |
+185,721
| New | +$719K | 0.36% | 33 |
|